The principal changes are as follows: GHK-Cu for non-injectable routes of administration is being removed from Category 1, and GHK-Cu for injectable routes of administration is separately being removed from Category 2
Secreted by L-cells found in the ileum of the small intestine and the large intestine, GLP-1 plays an important role in the body
Cagrilintide, the second generation (2020s) Novo Nordisk took the Pramlintide concept and applied the same half-life extension strategy that they used with Semaglutide: Kept the proline substitutions (anti-amyloid) Added a C20 fatty diacid via a -Glu linker to a lysine residue, albumin binding Additionally stabilized the N- and C-terminal positions Result: Cagrilintide with a half-life of 6.6 days (vs 50 minutes for Pramlintide)
Not only because of the antioxidant ability and also ALA is found to behave improve insulin sensitivity in skeletal muscles
Energy levels, mood, and cognitive function generally continue improving throughout this period
Recovery athletic and clinical-interest discussion often centers on recovery and tissue repair, again largely extrapolated from GH physiology rather than demonstrated in well-controlled trials of these peptides